All posts by Simmons Hanly Conroy
By Simmons Hanly Conroy | March 7, 2014
FDA Runs First Widespread Quality & Safety Evaluation on Generic Drugs
More than 80 percent of prescription drugs in the U.S. are being tested by the Food and Drug Administration (FDA) in its first widespread safety and quality evaluation. The effort will examine… Read More
By Simmons Hanly Conroy | March 3, 2014
Simmons Hanly Conroy Supports 2014 International Mesothelioma Symposium
The Firm is pleased to announce that it has renewed its support of the Mesothelioma Applied Research Foundation with a $25,000 donation to support the 2014 International Symposium on Malignant Mesothelioma. Over… Read More
By Simmons Hanly Conroy | February 28, 2014
Pharmaceutical News Wrap Up: February 2014
The pharmaceutical lawyers at the Firm are committed to keeping you up-to-date on the latest pharmaceutical news. Below is a short list of some of the most recent headlines concerning FDA recalls,… Read More
By Simmons Hanly Conroy | February 28, 2014
Asbestos and Mesothelioma News Wrap Up: February 2014
The mesothelioma lawyers at Simmons Hanly Conroy are dedicated to keeping you updated on the latest asbestos and mesothelioma news. Below is a short list of some of the most recent news… Read More
By Simmons Hanly Conroy | February 27, 2014
‘Rare Disease Day’ Event to be Broadcast Online on Feb. 28
More than 6,500 rare diseases affect about 25 million Americans. The NIH’s seventh annual celebration of Rare Disease Day strives to raise awareness about these diseases through a public, free event to… Read More
By Simmons Hanly Conroy | February 25, 2014
OSHA Updates Regulations to Protect Workers from Asbestos
Recently the Occupational Safety and Health Administration (OSHA) expanded and updated its Asbestos Fact Sheet. Within the Fact Sheet, the agency also discussed its various standards and regulations for protecting workers from… Read More
By Simmons Hanly Conroy | February 24, 2014
Studies Point to Inconsistencies in FDA Approval Process
Three new studies took a deeper look into the U.S. Food and Drug Administration (FDA) regulatory process. Results from the studies found that FDA approval does not necessarily mean the medication or… Read More
By Simmons Hanly Conroy | February 19, 2014
U.S. Senate Passes Tenth Annual Resolution to Designate ‘National Asbestos Awareness Week’
The Firm would like to personally thank Senator Max Baucus (D-MT) and cosponsors for passing the tenth annual resolution establishing April 1 to 7 as “National Asbestos Awareness Week.” Senate Resolution 336… Read More
By Simmons Hanly Conroy | February 14, 2014
Study Finds Antioxidant Supplements May Accelerate Cancer Growth
Two antioxidants, vitamin E and beta carotene may do more harm than good in lung cancer patients, a new study suggests. Researchers showed that, antioxidants accelerated the progression of tumors in mice… Read More
By Simmons Hanly Conroy | February 12, 2014
Aging Ameren Power Plants in St. Louis Pose Air Pollution Risk to Residents
The St. Louis area relies on aging coal-burning power plants owned by Ameren to provide the majority of its power. These coal-burning plants generate tons of coal ash waste that put Missouri… Read More
